Axol Bioscience Ltd.

📍 Cambridge, United Kingdom🗓 Founded 2013👥 47 employees💰 Last funded Jan 2015
Biotechnology Research🌐 axolbio.com
Website LinkedIn
At Axol Bioscience, we support your pursuit of more effective, safer therapies. Like you, we believe that having more human-relevant disease models will expand scientific knowledge and de-risk drug development. We use human iPSCs to achieve this and have been doing so since 2006. We use donated cells from patients and iPSC technology to build physiologically relevant in vitro models. We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well as cardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you better earlier-stage modeling and safety testing and later-stage efficacy evaluation and improved patient selection. With these data comes better insights, helping you de-risk projects, reduce costs, and save time during drug development.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Axol Bioscience Ltd.?
Axol Bioscience Ltd. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Axol Bioscience Ltd. last raise funding?
The most recent investment in Axol Bioscience Ltd. recorded on gritt.io was in January 2015.
When was Axol Bioscience Ltd. founded?
Axol Bioscience Ltd. was founded in 2013.
What industry is Axol Bioscience Ltd. in?
Axol Bioscience Ltd. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Axol Bioscience Ltd. based?
Axol Bioscience Ltd. is headquartered in Cambridge, United Kingdom.